169 parallel-computing-numerical-methods-"Simons-Foundation" positions at Nature Careers in Germany
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
immune cells, platelets and plasmatic factors in the context of cardiovascular and infectious diseases. You will use a broad range of in vitro and in vivo methods to dissect the interplay between
-
AI Methods for responsible and trustworthy AI Algorithmic fairness and explainable AI Methods for social and human-centered AI Within the professorship, you will establish a strong research program in
-
the central topics of the research program, such as diabetes and metabolic diseases, artificial intelligence and biomedical engineering, as well as personalized prevention. The Center's scientists work closely
-
interdisciplinary approaches and methods to study biomolecular condensates. The intrinsically interdisciplinary nature of this field poses particular challenges—especially in establishing a shared scientific data
-
are expected to apply state-of-the-art neuroscientific methods, such as optogenetics, chemogenetics, connectomics, electrophysiology, live imaging of neuronal activity, and AI-supported behavioural tracking with
-
the development program for the superconducting linear accelerator HELIAC (HElmholtz LInear ACcelerator). HELIAC consists of a normal-conducting injector LINAC and a superconducting section comprising up to four
-
on board! RESEARCH PROGRAM: The Institute of Medical Biochemistry, headed by Prof. Tim Lämmermann, is part of the Centre of Molecular Biology of Inflammation (ZMBE) and embedded within a vibrant
-
, BMBF, BIH, and others and engages in numerous national/international collaborations and consortia. In addition to our own laboratories at Charité, we have privileged access to Max-Delbrück Center
-
. Located on one of the largest life science campuses in Europe, the ZMBH hosts up to 15 independent research groups. We offer an outstanding international research environment, enriched by numerous
-
cancer genes for their impact on tumorigenesis, signaling activation, and targeted therapy response (e.g., Nat Commun 2019, Nat Cell Biol 2020, Nat Commun 2024, Sci Adv 2025, Nat Genet 2025). The method